Which coronary lesions should be treated with a drug eluting stent? A model-based cost-effectiveness analysis

被引：0
|
作者：
Carlier, SG [1 ]
Berger, A [1 ]
De Backer, TL [1 ]
Heyndrickx, G [1 ]
Wijns, W [1 ]
机构：
[1] Cardiovasc Cntr Aalst, Aalst, Belgium
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1886
引用
收藏
页码：408 / 408
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF ENDEVOR® DRUG-ELUTING STENT COMPARED TO BARE-METAL STENTS AND CORONARY ARTERY BYPASS GRAFT SURGERY IN SPAIN
    Rodriguez, Barrios J. M.
    Moreu, J.
    Cequier, A.
    Brosa, M.
    Vazquez, N.
    Hernandez, J.
    Crespo, C.
    Brasseur, P.
    VALUE IN HEALTH, 2008, 11 (06) : A419 - A419
  • [42] Cost-effectiveness of the Endeavor stent in de novo native coronary artery lesions updated with contemporary data
    Remak, Edit
    Manson, Stephanie
    Hutton, John
    Brasseur, Pascale
    Olivier, Elaine
    Gershlick, Anthony
    EUROINTERVENTION, 2010, 5 (07) : 826 - 832
  • [43] Cost-Effectiveness of Drug-Eluting Stents in Elderly Patients With Coronary Artery Disease: The SENIOR Trial
    Bulsei, Julie
    Butel, Thibault
    Varenne, Olivier
    Cook, Stephane
    Cuisset, Thomas
    Carrie, Didier
    Hovasse, Thomas
    Morice, Marie-Claude
    Sinnaeve, Peter R.
    Durand-Zaleski, Isabelle
    Sideris, Georgios
    Kedev, Sasko
    Garot, Philippe
    El Mahmoud, Rami
    Spaulding, Christian
    Helft, Gerard
    Diaz Fernandez, Jose F.
    Brugaletta, Salvatore
    Pinar-Bermudez, Eduardo
    Mauri Ferre, Josepa
    Commeau, Philippe
    Teiger, Emmanuel
    Sabate, Manel
    VALUE IN HEALTH, 2019, 22 (12) : 1355 - 1361
  • [44] Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: A model-based evaluation
    Fisman, David N.
    Chan, Christina H.
    Lowcock, Elizabeth
    Naus, Monika
    Lee, Victoria
    VACCINE, 2012, 30 (52) : 7601 - 7607
  • [45] COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS OF REFLEX TESTING MEN WITH INTERMEDIATE PSA LEVELS: A SYSTEMATIC MODEL-BASED ANALYSIS
    Jiao, B.
    Gulati, R.
    Hendrix, N.
    Gore, J. L.
    Rais-Bahrami, S.
    Tosoian, J. J.
    Kattan, M. W.
    Morgan, T. M.
    Etzioni, R.
    VALUE IN HEALTH, 2021, 24 : S50 - S50
  • [46] IMPACT AND COST-EFFECTIVENESS OF STRATEGIES TO ACCELERATE CERVICAL CANCER ELIMINATION IN NORWAY: A MODEL-BASED ANALYSIS
    Portnoy, Allison
    Pedersen, Kine
    Sy, Stephen
    Kim, Jane J.
    Burger, Emily A.
    MEDICAL DECISION MAKING, 2021, 41 (04) : E179 - E180
  • [47] Model-Based Analysis of Impact, Costs, and Cost-effectiveness of Tuberculosis Outbreak Investigations, United States
    Shrestha, Sourya
    Cilloni, Lucia
    Asay, Garrett R. Beeler
    Kammerer, J. Steve
    Raz, Kala
    Shaw, Tambi
    Cilnis, Martin
    Wortham, Jonathan
    Marks, Suzanne M.
    Dowdy, David
    EMERGING INFECTIOUS DISEASES, 2025, 31 (03) : 497 - 506
  • [48] MODEL-BASED COST-EFFECTIVENESS ANALYSIS OF TRABECTEDIN IN THE TREATMENT OF METASTATIC SOFT TISSUE SARCOMA IN JAPAN
    Ueda, M.
    Hirota, Y.
    Nishiuchi, Y.
    Moriwaki, K.
    VALUE IN HEALTH, 2019, 22 : S74 - S74
  • [49] A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women
    Yoshimura, M.
    Moriwaki, K.
    Noto, S.
    Takiguchi, T.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (02) : 643 - 652
  • [50] A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women
    M. Yoshimura
    K. Moriwaki
    S. Noto
    T. Takiguchi
    Osteoporosis International, 2017, 28 : 643 - 652
12345